A Phase 3 Study to Evaluate LL-BMT1 for the Treatment of Glaucoma or Ocular Hypertension
Latest Information Update: 23 Mar 2021
At a glance
- Drugs Bimatoprost (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Registrational; Therapeutic Use
- Acronyms SIGHT-3
- Sponsors MediPrint Ophthalmics
- 23 Mar 2021 New trial record